University of Texas at Southwestern — Dallas, Texas

University of Texas at Southwestern is a clinical research site located in Dallas, Texas, United States.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Texas at Southwestern has participated in 7 clinical trials with 2 currently active.

Therapeutic areas: Relapsed T-Cell Acute Lymphoblastic Leukemia, Relapsed T-Cell Lymphoblastic Lymphoma, Acute Lymphoblastic Leukemia.

Sponsors: Therapeutic Advances in Childhood Leukemia Consortium, University of Washington, Icahn School of Medicine at Mount Sinai.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Texas at Southwestern?

University of Texas at Southwestern has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Texas at Southwestern conducted?

University of Texas at Southwestern has 7 clinical trials on record, with 2 currently active. Their work covers Relapsed T-Cell Acute Lymphoblastic Leukemia, Relapsed T-Cell Lymphoblastic Lymphoma, Acute Lymphoblastic Leukemia.

Is University of Texas at Southwestern accredited by Crixeo Health?

Yes — University of Texas at Southwestern holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Texas at Southwestern?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.